| The social structural production of HIV risk among injecting drug users T Rhodes, M Singer, P Bourgois, SR Friedman, SA Strathdee Social science & medicine 61 (5), 1026-1044, 2005 | 1143 | 2005 |
| Structural interventions: concepts, challenges and opportunities for research KM Blankenship, SR Friedman, S Dworkin, JE Mantell Journal of Urban Health 83, 59-72, 2006 | 650 | 2006 |
| Reducing the risk of AIDS through methadone maintenance treatment JC Ball, WR Lange, CP Myers, SR Friedman Journal Of Health and social behavior, 214-226, 1988 | 631 | 1988 |
| Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial DC Des Jarlais, D Paone, J Milliken, CF Turner, H Miller, J Gribble, Q Shi, ... The Lancet 353 (9165), 1657-1661, 1999 | 630 | 1999 |
| HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987 DC Des Jarlais, SR Friedman, DM Novick, JL Sotheran, P Thomas, ... Jama 261 (7), 1008-1012, 1989 | 554 | 1989 |
| HIV incidence among injecting drug users in New York City syringe-exchange programmes DC Des Jarlais, M Marmor, D Paone, S Titus, Q Shi, T Perlis, B Jose, ... The Lancet 348 (9033), 987-991, 1996 | 529 | 1996 |
| Sociometric risk networks and risk for HIV infection. SR Friedman, A Neaigus, B Jose, R Curtis, M Goldstein, G Ildefonso, ... American journal of public health 87 (8), 1289-1296, 1997 | 425 | 1997 |
| Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. M Marmor, DC Des Jarlais, H Cohen, SR Friedman, ST Beatrice, N Dubin, ... AIDS (London, England) 1 (1), 39-44, 1987 | 421 | 1987 |
| Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users DONCDES JARLAIS, SR Friedman, W Hopkins Annals of Internal Medicine 103 (5), 755-759, 1985 | 410 | 1985 |
| The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection A Neaigus, SR Friedman, R Curtis, DC Des Jarlais, RT Furst, B Jose, ... Social science & medicine 38 (1), 67-78, 1994 | 402 | 1994 |
| Maintaining low HIV seroprevalence in populations of injecting drug users DC Des Jarlais, H Hagan, SR Friedman, P Friedmann, D Goldberg, ... Jama 274 (15), 1226-1231, 1995 | 367 | 1995 |
| HIV infection among intravenous drug users: epidemiology and risk reduction. DC Des Jarlais, SR Friedman AIDS (London, England) 1 (2), 67-76, 1987 | 355 | 1987 |
| Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. H Hagan, DC Jarlais, SR Friedman, D Purchase, MJ Alter American Journal of Public Health 85 (11), 1531-1537, 1995 | 339 | 1995 |
| AIDS and self-organization among intravenous drug users SR Friedman, DC Des Jarlais, JL Sotheran, J Garber, H Cohen, D Smith International Journal of the Addictions 22 (3), 201-219, 1987 | 323 | 1987 |
| International epidemiology of HIV and AIDS among injecting drug users DC Des Jarlais, SR Friedman, K Choopanya, S Vanichseni, TP Ward Aids 6 (10), 1053-1068, 1992 | 307 | 1992 |
| Continuity and change within an HIV epidemic: injecting drug users in New York City, 1984 through 1992 DC Des Jarlais, SR Friedman, JL Sotheran, J Wenston, M Marmor, ... Jama 271 (2), 121-127, 1994 | 288 | 1994 |
| A larger spectrum of severe HIV-1—related disease in intravenous drug users in New York City RL Stoneburner, DC Des Jarlais, D Benezra, L Gorelkin, JL Sotheran, ... Science 242 (4880), 916-919, 1988 | 281 | 1988 |
| HIV infection and intravenous drug use: critical issues in transmission dynamics, infection outcomes, and prevention DC Des Jarlais, SR Friedman, RL Stoneburner Reviews of infectious diseases 10 (1), 151-158, 1988 | 268 | 1988 |
| Social networks, risk-potential networks, health, and disease SR Friedman, S Aral Journal of Urban Health 78, 411-418, 2001 | 253 | 2001 |
| Social networks, drug injectors’ lives, and HIV SR Friedman, R Curtis, A Neaigus, B Jose, DC Des Jarlais Aids 1, 1999 | 250 | 1999 |
